drugset

drugset / Trial / NCT00195481

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

NCT00195481 ↗

Phase 4 Completed 100 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the safety of sirolimus tablets in renal allograft recipients in a postmarketing surveillance setting.

Timeline

Start: 2004-04
Primary completion: 2005-12
Completion: 2005-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sirolimus	Small molecule	—	—

Indications